The distribution of neuroligin4, an autism-related postsynaptic molecule, in the human brain.

Scientists studied a protein called NLGN4 that's linked to autism in some families. They looked at where this protein appears in human brains and found it's mainly in nerve cells throughout the brain. It was especially concentrated in brain areas that control social behavior, learning, and sleep patterns - all things that can be challenging for autistic people. This helps explain why changes in this protein might contribute to autism symptoms.

This 2023 study examined the distribution of NLGN4, a protein linked to rare familial autism, in human brain tissue using specialized antibodies. Researchers found NLGN4 is expressed almost exclusively in neurons with widespread distribution. Notably, NLGN4 showed consistently high expression in hypothalamic neurons producing oxytocin and vasopressin, which are involved in social behavior. Strong signals were also found in pyramidal cells of the cerebral cortex and hippocampus, as well as neurons in brain regions controlling arousal and mood.

Purkinje cells showed little to no NLGN4 expression. The distribution pattern suggests NLGN4 functions in neural systems governing intellectual abilities, social behavior, and sleep-wake cycles - all commonly affected in autism.

The distribution pattern of NLGN4 in brain regions controlling social behavior, cognition, and sleep-wake cycles provides neurobiological insight into autism phenotypes. This may inform understanding of how NLGN4X mutations contribute to autism symptoms, particularly social and cognitive difficulties.

Study appears descriptive without functional analysis. Sample size not reported. No comparison with neurotypical controls mentioned. Lacks information about study methodology details and potential confounding factors in tissue analysis.

NLGN4X was identified as a single causative gene of rare familial nonsyndromic autism for the first time. It encodes the postsynaptic membrane protein Neuroligin4 (NLGN4), the functions and roles of which, however, are not fully understood due to the lack of a closely homologous gene in rodents. It has been confirmed only recently that human NLGN4 is abundantly expressed in the cerebral cortex and is localized mainly to excitatory synapses. However, the detailed histological distribution of NLGN4, which may have important implications regarding the relationships between NLGN4 and autistic phenotypes, has not been clarified.

In this study, we raised specific monoclonal and polyclonal antibodies against NLGN4 and examined the distribution of NLGN4 in developing and developed human brains by immunohistochemistry. We found that, in the brain, NLGN4 is expressed almost exclusively in neurons, in which it has a widespread cytoplasmic pattern of distribution. Among various types of neurons with NLGN4 expression, we identified consistently high expression of NLGN4 in hypothalamic oxytocin (OXT)/vasopressin (AVP)-producing cells. Quantitative analyses revealed that the majority of OXT/AVP-producing neurons expressed NLGN4.

NLGN4 signals in other large neurons, such as pyramidal cells in the cerebral cortex and hippocampus as well as neurons in the locus coeruleus and the raphe nucleus, were also remarkable, clearly contrasting with no or scarce signals in Purkinje cells. These data suggest that NLGN4 functions in systems involved in intellectual abilities, social abilities, and sleep and wakefulness, impairments of which are commonly seen in autism.